Down 50%: Should You Buy Corcept?

Editor's Note: This video was filmed on May 7th.

Corcept Therapeutics  (NASDAQ: CORT  ) shares were slammed last week after a phase 3 trial for mifepristone to treat patients with depression was stopped after an independent data monitoring committee indicated that the drug would probably not provide a statistically significant benefit to currently enrolled patients. The data was from 266 patients in a study that was intended to expand up to 450 patients, but instead of sinking more money into the study by continuing, Corcept's management decided to end the trial and focus on other potential indications.

Indications as diverse as breast cancer, post-traumatic stress disorder, and alcohol dependence.

What to make of this diversity? Does it signify a management that is scattershotting?

In the video below, Motley Fool health care analysts Michael Douglass and David Williamson give you their answer and their thoughts on the company.

Looking for a potentially better option? Try this top stock on for size.
Give me five minutes and I'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks 1 stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.


Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2958410, ~/Articles/ArticleHandler.aspx, 8/1/2014 5:04:55 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement